The George Washington University Cancer Center (GWCC) incorporates all of the existing cancer-related activities at the George Washington University (GW), GW School of Medicine and Health Sciences, the GW Medical Faculty Associates, the GW Hospital, and GW’s Milken Institute School of Public Health, and serves as a platform to refocus and re-energize the university’s efforts in cancer research and patient care.
Our vision is to become a leading innovator in basic, population, and clinical research, and become a premier destination for personalized cancer care. We aim to be comprehensive in scope, with an initial heightened emphasis on a select niche of specialties. Our strengths include breast cancer, gastrointestinal cancer (cancers of the digestive system), urologic cancers (cancers of the genital and urinary organs), immunology and immunotherapy (stimulating the body’s immune system to attack cancer cells), and hematologic malignancies (blood cancers and stem cell transplant). Ultimately, the purpose of the GWCC is to improve outcomes for all cancer patients.
In addition to innovative research and personalized care, the third pillar of our vision is national leadership in cancer policy. There is a pronounced need to expand access to cancer care to all patients, including historically underserved populations. To do this, change is needed. GWCC has all the right elements here in Washington, D.C. to build a dynamic cancer policy program of distinction that will work to improve cancer health systems nationwide.